Shu-Chen Liu

Title: Innovations in Cancer Treatment by Shu-Chen Liu

Introduction

Shu-Chen Liu is a notable inventor based in Tao-Yuan, Taiwan. He has made significant contributions to the field of cancer treatment, particularly in enhancing the effectiveness of radiotherapy. His innovative approach focuses on the role of leukemia inhibitory factor in cancer diagnosis and treatment.

Latest Patents

Shu-Chen Liu holds a patent titled "Potentiation of nanopharyngeal cancer radiotherapy by inhibitors of leukemia inhibitory factor." This patent outlines a method for evaluating cancer diagnosis following radiotherapy. The process involves providing a serum sample from a cancer patient prior to treatment and measuring the concentration of leukemia inhibitory factor in the sample. Additionally, the patent describes a method for enhancing cancer radiotherapy by administering a leukemia inhibitory factor inhibitor or receptor inhibitor to patients in need.

Career Highlights

Shu-Chen Liu is affiliated with Chang Gung University, where he continues to advance research in cancer therapies. His work has garnered attention for its potential to improve patient outcomes in cancer treatment.

Collaborations

Shu-Chen Liu collaborates with esteemed colleagues, including Yu-Sun Chang and Ngan-Ming Tsang. Their combined expertise contributes to the ongoing research and development of innovative cancer treatment methods.

Conclusion

Shu-Chen Liu's contributions to cancer treatment through his innovative patent demonstrate the potential for improved therapeutic strategies. His work at Chang Gung University and collaborations with fellow researchers highlight the importance of continued innovation in the fight against cancer.